Nolicin (Norfloxacin)

Norfloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. Inhibiting these targets prevents bacterial cell division and leads to bacterial death, providing a bactericidal effect against a broad range of pathogens.

The dosage of Nolicin is determined by the prescribing clinician based on the infection type, severity, patient age, renal function and other clinical factors. Patients should follow the exact regimen provided by their healthcare professional.

Noricin is classified as pregnancy category C, meaning risk cannot be ruled out. It should only be used during pregnancy when the potential benefit justifies the potential risk to the fetus. Norfloxacin is excreted in breast milk, so breastfeeding mothers should consult their physician before use.

To order Nolicin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Noricin belongs to the fluoroquinolone class, offering broad‑spectrum activity and excellent tissue penetration, especially in the prostate and urinary tract. Compared with beta‑lactams, it provides once‑daily oral dosing and a lower risk of resistance in certain pathogens, but it carries class‑specific warnings such as tendon toxicity and QT prolongation.

Noricin should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date printed on the label.

Nolicin is taken orally, usually with a full glass of water. It can be taken with or without food, but patients should avoid concurrent intake of antacids or supplements containing calcium, magnesium or aluminium, as these may reduce absorption.

Serious risks include tendon rupture or tendinitis, especially in older adults or those on corticosteroids; QT interval prolongation leading to potentially fatal arrhythmias; severe allergic reactions such as anaphylaxis; Clostridioides difficile‑associated colitis; and peripheral neuropathy. Prompt medical attention is required if any of these occur.

Noricin should not be used by individuals with a known hypersensitivity to norfloxacin or other fluoroquinolones. It is also contraindicated in patients with a history of tendon disorders related to fluoroquinolone use, and it should be avoided in children and adolescents unless specifically indicated, due to the risk of musculoskeletal adverse effects.